| Announce Date | 10/30/2025 | 
| EPS Normalized Actual | $1.03 (Beat by $0.08) | 
| EPS GAAP Actual | $1.03 (Beat by $0.08) | 
| Revenue Actual | $1.04755B | 
| Revenue Surprise | Beat by $1047.55M | 
| Announce Date | 10/01/2025 (Pre-Market) | 
| EPS Normalized Estimate | $2.985 | 
| EPS GAAP Estimate | $2.985 | 
| Revenue Estimate | $1.09342155B | 
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| Dec 2026 | 9.43 | 10.69 | 9.31674 | 9.56896 | 1 | 
| Dec 2025 | 9.75 | 10.34 | 9.75 | 9.75 | 1 | 
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss | 
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 1 | -1.54542 | 1.04755B | 2.95% | -38.72M | 
| FQ1 2025 (Mar 2025) | 1.17 | 1.17 | 1.00342B | 6.97% | 1003.42M | 
| FQ4 2024 (Dec 2024) | 0.45 | 0.45 | 0.846123B | -2.36% | 846.12M | 
| FQ3 2024 (Sep 2024) | 1.88 | 1.88 | 0.919444B | -0.13% | 919.44M | 
| FQ2 2024 (Jun 2024) | 2.2 | 2.2 | 1.01662B | 100% | 1016.62M | 
| FQ1 2024 (Mar 2024) | 1.62 | 1.62 | 0.933492B | 3.58% | 933.49M | 
| FQ4 2023 (Oct 2023) | 1.84 | 1.84 | 0.866073B | -9.91% | 866.07M | 
| FQ3 2023 (Jul 2023) | 1.97 | 1.97 | 0.920685B | -20.79% | 920.69M | 
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
2.985
Consensus Revenue Estimates
1.09342155B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 1.74 | -- | 1.69447 | 1.80755 | 3 | 
| FQ3 2026 (Sep 2026) | 2.53 | -- | 2.4638 | 2.62822 | 3 | 
| FQ2 2026 (Jun 2026) | 3.36 | 70.24 | 3.27209 | 3.49045 | 3 | 
| FQ1 2026 (Mar 2026) | 1.87 | 37.43 | 1.82107 | 1.9426 | 3 | 
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2026 (Dec 2026) | 0.95B | -- | 0.93B | 0.98B | 2 | 
| FQ3 2026 (Sep 2026) | 1.08B | -- | 1.06B | 1.11B | 2 | 
| FQ2 2026 (Jun 2026) | 1.2B | 12.59 | 1.17B | 1.23B | 2 | 
| FQ1 2026 (Mar 2026) | 1.05B | 4.41 | 1.03B | 1.08B | 2 | 
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts | 
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 | 
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 | 
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 | 
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 | 
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 2.54542 | 1 | -1.54542 | -154.54% | 
| FQ1 2025 (Mar 2025) | 1.17 | 1.17 | 100% | |
| FQ4 2024 (Dec 2024) | 0.45 | 0.45 | 100% | |
| FQ3 2024 (Sep 2024) | 1.88 | 1.88 | 100% | |
| FQ2 2024 (Jun 2024) | 2.2 | 2.2 | 100% | |
| FQ1 2024 (Mar 2024) | 1.62 | 1.62 | 100% | |
| FQ4 2023 (Oct 2023) | 1.84 | 1.84 | 100% | |
| FQ3 2023 (Jul 2023) | 1.97 | 1.97 | 100% | 
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % | 
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $1.09B | $1.05B | $-38.72M | -3.7% | 
| FQ1 2025 (Mar 2025) | $0B | $1B | $1003.42M | 100% | 
| FQ4 2024 (Dec 2024) | $0B | $0.85B | $846.12M | 100% | 
| FQ3 2024 (Sep 2024) | $0B | $0.92B | $919.44M | 100% | 
| FQ2 2024 (Jun 2024) | $0B | $1.02B | $1016.62M | 100% | 
| FQ1 2024 (Mar 2024) | $0B | $0.93B | $933.49M | 100% | 
| FQ4 2023 (Oct 2023) | $0B | $0.87B | $866.07M | 100% | 
| FQ3 2023 (Jul 2023) | $0B | $0.92B | $920.69M | 100% |